Literature DB >> 11707161

3,4-methylenedioxymethamphetamine (MDMA): a review.

G O'Leary1, J Nargiso, R D Weiss.   

Abstract

This article reviews the history, pharmacology, and adverse events associated with the use of 3,4-methylenendioxymethamphetamine (MDMA), commonly known as Ecstasy. Past research describing the neurotoxic effects of MDMA in animals, current research on the neurotoxic effects of MDMA in humans, and the attendant changes in psychologic functioning will be highlighted in this review. Finally, the limitations of human research on the effects of MDMA and suggestions for future MDMA research will be discussed.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11707161     DOI： 10.1007/s11920-001-0041-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   8.081


  73 in total

1.  Chemical analysis of ecstasy pills.

Authors:  M Baggott; B Heifets; R T Jones; J Mendelson; E Sferios; J Zehnder
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

2.  Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

Authors:  P McGuire; T Fahy
Journal:  BMJ       Date:  1991-03-23

3.  Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.

Authors:  G A Ricaurte; K T Finnegan; I Irwin; J W Langston
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Subjective reports of the effects of MDMA in a clinical setting.

Authors:  G Greer; R Tolbert
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

Review 5.  The background and chemistry of MDMA.

Authors:  A T Shulgin
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

6.  Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.

Authors:  H Zhao; R Brenneisen; A Scholer; A J McNally; M A ElSohly; T P Murphy; S J Salamone
Journal:  J Anal Toxicol       Date:  2001 May-Jun       Impact factor: 3.367

7.  Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

Authors:  M J Morgan
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

8.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

Authors:  J H Krystal; L H Price; C Opsahl; G A Ricaurte; G R Heninger
Journal:  Am J Drug Alcohol Abuse       Date:  1992       Impact factor: 3.829

9.  (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.

Authors:  G A Ricaurte; L S Forno; M A Wilson; L E DeLanney; I Irwin; M E Molliver; J W Langston
Journal:  JAMA       Date:  1988-07-01       Impact factor: 56.272

10.  3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.

Authors:  R A Lyon; R A Glennon; M Titeler
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
View more
  5 in total

1.  Evidence for significant polydrug use among ecstasy-using college students.

Authors:  Eric D Wish; Dawn Bonanno Fitzelle; Kevin E O'Grady; Margaret H Hsu; Amelia M Arria
Journal:  J Am Coll Health       Date:  2006 Sep-Oct

2.  3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection.

Authors:  Daniel A Nelson; Sam J Singh; Amy B Young; Melanie D Tolbert; Kenneth L Bost
Journal:  Drug Alcohol Depend       Date:  2011-01-26       Impact factor: 4.492

3.  Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague-Dawley rats.

Authors:  Sara Soleimani Asl; Kazem Mousavizadeh; Kazem Mousavizedeh; Bagher Pourheydar; Mansoureh Soleimani; Elnaz Rahbar; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2013-08-24       Impact factor: 3.584

4.  Ecstasy-induced caspase expression alters following ginger treatment.

Authors:  Sara Soleimani Asl; Bagher Pourheydar; Fataneh Dabaghian; Akram Nezhadi; Amir Roointan; Mehdi Mehdizadeh
Journal:  Basic Clin Neurosci       Date:  2013

5.  Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats.

Authors:  Sara Soleimani Asl; Mohammad Hassan Farhadi; Kazem Moosavizadeh; Ali Samadi Kuchak Saraei; Mansoure Soleimani; Seid Behnameldin Jamei; Mohammad Taghi Joghataei; Alireza Samzadeh-Kermani; Hamed Hashemi-Nasl; Mehdi Mehdizadeh
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.